Oncology & Cancer

High doses of saw palmetto don't impact serum PSA

(HealthDay)—Compared with placebo, saw palmetto, even at a dose as high as 960 mg, does not affect serum prostate-specific antigen (PSA) levels in men with lower urinary tract symptoms, according to research published in ...

Attention deficit disorders

Study finds early signs that may help predict ADHD risk

Information available at birth may help to identify children with higher likelihood of developing ADHD, according to new research from RCSI University of Medicine and Health Sciences.

Medical research

Bacteria make us feel pain... and suppress our immune response

The pain of invasive skin infections caused by methicillin-resistant Staphylococcus aureus, and possibly other serious, painful infections, appear to be induced by the invading bacteria themselves, and not by the body's immune ...

Diseases, Conditions, Syndromes

UTI discovery may lead to new treatments

Sufferers of recurring urinary tract infections (UTIs) could expect more effective treatments thanks to University of Queensland-led research.

Medications

FDA approves first-in-class treatment for myasthenia gravis

(HealthDay)—Vyvgart (efgartigimod), a neonatal Fc receptor blocker (FcRn), was approved to treat generalized myasthenia gravis in adults who test positive for the anti-acetylcholine receptor (AChR) antibody, the U.S. Food ...

page 10 from 40